CN108998441A - A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural method - Google Patents

A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural method Download PDF

Info

Publication number
CN108998441A
CN108998441A CN201810868902.5A CN201810868902A CN108998441A CN 108998441 A CN108998441 A CN 108998441A CN 201810868902 A CN201810868902 A CN 201810868902A CN 108998441 A CN108998441 A CN 108998441A
Authority
CN
China
Prior art keywords
culture medium
ball
culture
tumour
dimensional nodule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810868902.5A
Other languages
Chinese (zh)
Inventor
朱震威
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Hospital of Southern Medical University
Original Assignee
Shenzhen Hospital of Southern Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Hospital of Southern Medical University filed Critical Shenzhen Hospital of Southern Medical University
Priority to CN201810868902.5A priority Critical patent/CN108998441A/en
Publication of CN108998441A publication Critical patent/CN108998441A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/003D culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/78Cellulose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/90Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides a kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural methods.The additive by thickener and glucosamine gel group at, thickener is selected from one of methylcellulose, ethyl cellulose, basement membrane matrix, collagen or a variety of combinations, and gelling agent, which is selected from, ties one of cold foot, alginic acid or Ago-Gel or a variety of combinations.The culture medium of the three-dimensional nodule ball, including tumor cell culture base and three-dimensional nodule ball culture medium additive above-mentioned.Culture medium of the present invention can be in High Density Cultivation as the result is shown for various kinds of cell system, hence it is evident that reduces the aggregation of tumour ball, fusion.

Description

A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball culture Method
Technical field
Invention is related to biological field, and in particular to a kind of culture medium for preparing tumour ball and its tumour ball are a large amount of three-dimensional (3D) The method of preparation.
Background technique
Tumor stem cell (Cancer stem cells) theory thinks have a group to have stem cell properties in tumor tissues Tumour cell, they are only the basic reason of tumorigenesis, Preventive.Tumour ball culture is presently the most common The method of culture and enrichment tumor stem cell, identification of cell stemness ability.It is all in serum-free and (the ultralow adherency of non-adherent environment Ware) under cultivated, through culture in one week or so is part of there is " stemness " characteristic cell to form tumour ball.Culture scheme has more Kind, such as classical DMEM/F12+20ng/ml EGF+20ng/ml FGF+2%B27 scheme.Specifically added ingredient includes: Epidermal growth factor (EGF), fibroblast growth factor (FGF), leukocyte inhibitory factor (LIF), B27, insulin, conversion Growth factor-beta (TGF-β) etc..
Traditional tumour ball cultivation used by the prior art is easy to happen aggregation, adherency, agglomerating, loses tumour ball list The feature of cell origin, and tumour ball culture amount is few, costly, operation difficulty is big.
Summary of the invention
It is an advantage of the invention to provide a kind of three-dimensional (3D) tumour ball culture medium additives.
Second object of the present invention is, provides a kind of three-dimensional nodule ball culture medium.
Third object of the present invention is, provides a kind of three-dimensional nodule ball cultural method.
According to an aspect of the present invention, a kind of three-dimensional nodule ball culture medium additive is provided, by thickener and gel Agent composition;
Inventor thinks in conventional cell suspension medium, due under non-adherent environment, without attachment point in cell growth, Will occur under extraneous micro force mobile and then lead to aggregation, adhere to, is agglomerating.Since tumour ball is easy aggregation, adherency Therefore often by reducing cell inoculation quantity come the less above phenomenon in actual application;This results in the tumour ball amount of culture It is fewer.And the present invention is found surprisingly that and can be achieved with high density, big by the way that two kinds of biomaterials of thickener and gelling agent are added The purpose of amount culture tumour ball.
Thickener can increase culture medium viscosity to limit movement of the tumour ball in all directions, and gelling agent, which has, promotees gel Effect makes culture medium generate certain degree of hardness and then controls the sinking speed of tumour ball, generates the effect of 3D culture.
Further, thickener is in methylcellulose (MC), ethyl cellulose, basement membrane matrix, collagen One or more combinations;Gelling agent is selected from one of gellan gum, alginic acid or Ago-Gel or a variety of combinations;
Still further, the thickener and the mass ratio of gelling agent are 1-100:1, preferably 5-15:1, more preferably For 10:1;
When using additive, the mass volume ratio of the thickener and culture medium is 0.1-0.5%, preferably 0.3%;It is solidifying The mass volume ratio of jelly and culture medium be 0.01%-0.05%, preferably 0.03%.
According to a further aspect of the invention, a kind of culture medium of three-dimensional nodule ball is provided comprising tumour cell training Base and three-dimensional nodule ball culture medium additive above-mentioned are supported, the tumor cell culture base is selected from arbitrary cell commonly used in the art Culture medium, preferably serum-free tumour ball culture medium;
Further, the culture medium of three-dimensional nodule ball of the invention be in DMEM/F12 be added EGF, FGF, B27, 0.3% methylcellulose (MC) and the cold foot of 0.03% knot (GG) is made;
Still further, the culture medium of three-dimensional nodule ball of the invention be in DMEM/F12 be added 20ng/ml EG F, The FGF of 20ng/ml, 2% B27 (adding commodity B27 solution according to volume 1:50), 0.3% methylcellulose (MC) and 0.03% gellan gum (GG) is made;
The preparation method of three-dimensional nodule ball culture medium of the present invention includes the following steps:
1) it prepares three-dimensional nodule ball culture medium additive: thickener and gelling agent being dissolved with water respectively, are configured to sterile Aqueous thickener solution and gelling agent aqueous solution;
2) culture medium for the culture three-dimensional nodule ball that suspends is prepared: aqueous thickener solution, gelling agent aqueous solution and tumour is thin The mixing of born of the same parents' culture medium obtains suspending and cultivates the culture medium of three-dimensional nodule ball.
Wherein, the thickener in step 1) is formulated as 0.1g/ml-0.5g/ml (preferably 0.3g/ml), and gelling agent is prepared For 0.01g/ml-0.05g/ml (preferably 0.03g/ml).
According to a further aspect of the invention, the method for three-dimensional nodule ball culture is provided comprising following steps:
Tumour cell is digested and is counted by I, and the tumor cell inoculation digested is arrived aforementioned three-dimensional nodule ball to kind and is trained It supports in base,
Centrifugal process replaces culture medium after II culture tumour cell turns yellow to culture medium, cultivates thereafter to the complete shape of tumour ball At;
Wherein, the tumor cell density digested described in step I is 103-105Cells/ml is significantly higher than traditional culture Base is inoculated with quantity (103cells/ml);
Wherein, cell culture is in culture bottle or culture dish, condition of culture, and 37 DEG C, 5%CO2
Wherein, culture medium process is replaced are as follows:
1) culture medium containing tumour ball is collected into centrifuge tube, and isometric DMEM solution is added and is diluted;
2) centrifuge is centrifuged;
3) old culture medium is removed, new culture medium is added.
Wherein, the diameter of the tumour ball of acquisition is more than 100 microns.
The utility model has the advantages that
Culture medium additive of the invention can change conventional medium property, and to the observation of tumour ball, counting, statistics, knot Fruit shows that new technology can obviously reduce the aggregation of tumour ball, adherency, fusion, and high density, mass propgation are realized in culture bottle, real Now to the enrichment culture of tumor stem cell, and the cell stemness of tumour ball is not reduced, obtain in various kinds of cell system good Effect.
Detailed description of the invention
Influence of Fig. 1 MC to tumour ball aggregation fusion in culture medium
The influence that Fig. 2 GG settles tumour ball in culture medium
5-8F tumour ball forming process in Fig. 3 the application 3D culture medium
Seeding cells: inoculating cell;Medium change: replacement culture medium;
The tumour ball that the other cancerous cell lines of Fig. 4 are formed in the application 3D culture medium
The stemness related gene transcriptional level for the tumour ball that Fig. 5 the application 3D culture medium and conventional medium are formed compares
Wherein, ordinate indicates that mRNA expression multiple changes
The stemness correlative protein expression level for the tumour ball that Fig. 6 the application 3D culture medium and conventional medium are formed compares
From left to right, each swimming lane is respectively attached cell, the tumour ball of conventional medium formation, the application 3D culture medium shape At tumour ball
Specific embodiment
It can be best understood from the present invention by the following examples, for illustration purposes, but be not limited to this hair Bright claim.The present patent application institute is commercially available using reagent material.
Cancerous cell line used in this application: CNE cell line 5-8F, CNE cell line Sune1, National People's Congress's cell Lung cancer cell line H460, human colon cancer cell line SW480.Above-mentioned cell line derives from triumphant base biology Co., Ltd.
Porcine HGF EGF, FGF and B27 used in this application are purchased from PeproTech company of the U.S..
1 3D of the embodiment culture selection of biomaterial
By a variety of biomaterial (methylcellulose (MC), gellan gum (GG), basement membrane matrixs, collagen, seaweed to be measured Acid and agar) respectively with identical concentration, it is added to conventional medium (DMEM/F12+EGF 20ng/ml+FGF 20ng/ml+ B27 2%) in be configured to 3D culture medium, with 10000cells/ml human nasopharyngeal carcinoma 5-8F cell inoculation, observation is swollen after a week for culture Tumor ball culture effect, MAIN OUTCOME MEASURES anti-adhesion ability, anti-settling ability, sample treatment difficulty and build cost.Synthesis is commented Valence the results are shown in Table 1.
The feature of 1. various biological material of table.
0.3%MC is added in culture medium can effectively inhibit the fusion of 5-8F tumour ball, prevent as shown in Figure 1, cultivating containing MC The tumour ball ratio of normal size is much larger than without MC culture medium in base.The fusion rate of 5-8F tumour ball is from 15.8 ± 3.9 Drop to 2.9 ± 1.0%, and similarly, the fusion rate of H460 tumour ball drops to 3.4 ± 0.7% from 19.7 ± 4.0, because This MC can effectively inhibit the spontaneous fusion of tumour ball.
0.03%GG is added in culture medium can effectively prevent the sedimentation of tumour ball, as shown in Fig. 2, several in the culture medium without GG It can't see suspension tumor ball, and tumour ball suspends in order in the culture medium containing GG, is distributed according to 3D.
Embodiment 2 prepares culture 3D culture systems culture medium
The scheme of 3D tumour ball culture systems: DMEM/F12+EGF 20ng/ml+FGF 20ng/ml+B272%+ methyl is fine It ties up element (MC) 0.3%+ and ties cold foot (GG) 0.03%.
MC and GG saves the preparation of liquid: 3g MC and 0.3g GG powder is dissolved in respectively in the tri-distilled water of 100ml, under room temperature It is sufficiently stirred 48 hours using magnetic stirring apparatus, dissolves fibre composition sufficiently;Mixing is placed in autoclave sterilizer, 160 DEG C, be greater than 2 hours, to remove endotoxin, temperature is down to room temperature after sterilizing, firmly shake it is repeated multiple times, up to no grumeleuse is Only, set 4 DEG C it is spare, or packing after -20 DEG C preservation.
The preparation of culture medium in 3D culture systems: traditional tumour ball culture medium 500ml DMEM/F12+EGF is prepared first 20μg+FGF 10μg+B27 10ml;The prepared MC solution of 55ml and the configured GG solution of 5ml are added again;Final 3D is swollen Tumor ball culture medium, which is prepared, to be completed.
Embodiment 3 largely prepares tumour ball using 3D culture medium.
Tumour ball incubation:
1. by the good purpose human nasopharyngeal carcinoma 5-8F cell dissociation of growth conditions and counting;
2. according to experiment purpose by certain amount (according to research purpose, 103-105Cells/ml cell inoculation) is trained to 3D It supports in base, is cultivated in culture bottle or culture dish, 37 DEG C, 5%CO2
3.3D culture systems change liquid: at the 3-5 days of tumour ball culture, carrying out culture medium replacement, be with solution turned yellow Basic judgment criterion.
Change liquid process: 1) collect the 3D culture medium containing tumour ball into centrifuge tube, and be added isometric DMEM solution into Row dilution;
2) centrifuge is centrifuged 200g, is centrifuged 10 minutes;
3) old culture medium is removed, new culture medium is added.
4. the formation that diameter is more than 100 μm of tumour ball can be observed after 5-7 days, isometric DMEM solution is added, from The heart obtains tumour ball, carries out downstream research.
As shown in figure 3, at head two days of culture, due to non-adhering suspension culture environment, there are some natural death of cerebral cells, 5 After it, the partial size of tumour ball reaches 50-100 μm.After 7 days, tumour spherolite diameter reaches 100-200 μm, and the partial size of tumour ball Uniform, the case where shape is round and smooth, fusion, is less.
And as shown in figure 4, Sune1, H460 and SW480 cell line can also form ideal tumour in the application 3D culture medium Ball.
The Nature comparison for the tumour ball that the tumour ball and conventional medium that 4 the application 3D culture medium of embodiment is formed are formed
4.1CD133 detection
Method: the anti-CD133- phycoerythrin antibody of use (Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany, catalog no.130-080-801,1:10) detection cell culture. Attached cell and tumour ball are harvested, single cell suspension is decomposed by trypsase, and use CD133- in the dark at 4 DEG C PE is dyed 30 minutes.Using flow cytomery staining cell, data analysis is carried out using FlowJo software 7.6.
5-8F cell and H460 cell are tested, the tumour ball institute that conventional medium and the application 3D culture medium obtain The CD133 amount of expression is identical, is all 4 times of CD133 amount expressed by parent attached cell.
The detection of 4.2 stemness related genes
Method: attached cell is extracted using RNAiso Plus reagent (Takara Bio, Inc., Otsu, Japan) and is swollen Tumor glomus cell total serum IgE.Pass through ultraviolet specrophotometer (ThermoNanoDrop 2000, Thermo Fisher Scientific, Inc., Waltham, MA, USA) measurement RNA concentration.Then PrimeScript RT kit is used (Takara Bio, Inc.), according to specification, carry out RT.Then, using SYBR Green RT-qPCR Master Mix (Takara Bio, Inc.) carries out quantitative PCR.For eight aggressiveness combination transcription factors 4 (Oct-4), (sex-determining region Y)-box The primer sequence of 2 (Sox2), Nanog and GAPDH are listed in tablei.GAPDH, which is used as, refers to gene.PCR reaction is related at 95 DEG C Then lower denaturation 2 minutes keeps carrying out within 15 seconds 42 circulations at 95 DEG C, is kept for 30 seconds, then carried out most at 60 DEG C Incubation afterwards continues 30 seconds at 72 DEG C.
Have detected 5-8F cell and H460 cell, as shown in figure 5, conventional medium and the application 3D culture medium formed it is swollen The stemness related gene transcriptional level of tumor ball is approximate.
The detection of 4.30 stemness GAP-associated protein GAPs
Method: 5 minutes removing culture mediums, PBS washing are centrifuged with 200 × g to tumour ball and collected at room temperature in EP pipe In.Next, tumour ball is fixed in EP pipe with 4% paraformaldehyde.Rabbit-anti mankind primary antibody, including Sox2 is added (ab97959;1:1,000), Oct4 (ab19857;1:200) and Nanog (ab109250;1:200;It is all from Abcam), 4 DEG C Concussion is incubated for overnight incubation.It is then cleaned with PBS and washes tumour ball three times, add the goat antirabbit secondary antibody (P0183 in conjunction with Cy3; Beyotime Institute of Biotechnology;;1:1,500), tumour ball is incubated at room temperature 1 hour.DAPI For nuclear staining (blue).Fluorescence microscope image.
Have detected 5-8F cell and H460 cell, as shown in fig. 6, conventional medium and the application 3D culture medium formed it is swollen The stemness correlative protein expression of tumor ball is horizontal approximate.

Claims (6)

1. a kind of three-dimensional nodule ball culture medium additive, which is characterized in that contain methylcellulose and gellan gum.
2. culture medium additive according to claim 1, wherein the mass ratio of methylcellulose and gellan gum is 10:1.
3. a kind of three-dimensional nodule ball culture medium, ingredient is tumor cell culture culture medium, which is characterized in that also contains methyl Cellulose and gellan gum.
4. culture medium according to claim 3, ingredient is DMEM/F12+EGF 20ng/ml+FGF 20ng/ml+B27 2%, the B27 are with volume ratio 1:50 addition, which is characterized in that also contain methylcellulose and gellan gum.
5. culture medium according to claim 3 or 4, wherein calculated by mass volume ratio, contain 0.3% Methyl cellulose The plain gellan gum with 0.03%.
6. a kind of cultural method of three-dimensional nodule ball comprising following steps:
1) tumour cell is digested and is counted, and by the tumour cell digested by 103-105Cells/ml is inoculated into right and wants It asks in the described in any item three-dimensional nodule ball culture mediums of 3-5,37 DEG C, 5%CO2Culture;
2) at the 3-5 days of tumour ball culture, until solution turned yellow, replaces culture medium;
The replacement culture medium operation are as follows:
The culture medium of the ball containing tumour is added into centrifuge tube, isometric DMEM solution dilution is added;
Centrifuge is centrifuged with 200g, is centrifuged 10 minutes;
Old culture medium is removed, new culture medium is added;
3) after cultivating 5-7 days, diameter to be formed is more than 100 μm of tumour ball, and isometric DMEM solution is added, and centrifugation obtains tumour Ball.
CN201810868902.5A 2018-08-02 2018-08-02 A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural method Pending CN108998441A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810868902.5A CN108998441A (en) 2018-08-02 2018-08-02 A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810868902.5A CN108998441A (en) 2018-08-02 2018-08-02 A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural method

Publications (1)

Publication Number Publication Date
CN108998441A true CN108998441A (en) 2018-12-14

Family

ID=64594931

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810868902.5A Pending CN108998441A (en) 2018-08-02 2018-08-02 A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural method

Country Status (1)

Country Link
CN (1) CN108998441A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110616185A (en) * 2019-09-25 2019-12-27 华东理工大学青岛创新研究院 Multi-cell tumor ball and high-flux preparation method thereof
CN112961821A (en) * 2021-02-24 2021-06-15 四川大学华西医院 Method for efficiently three-dimensionally culturing vascular endothelial cells

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103865876A (en) * 2014-03-26 2014-06-18 西北民族大学 Method for primary culture of tumor cells
CN104640974A (en) * 2012-07-24 2015-05-20 日产化学工业株式会社 Culture medium composition, and method for culturing cell or tissue using said composition
CN105934511A (en) * 2014-01-23 2016-09-07 日产化学工业株式会社 Culture medium composition
CN106414707A (en) * 2014-01-23 2017-02-15 日产化学工业株式会社 Method for producing culture medium composition
CN107208059A (en) * 2015-01-30 2017-09-26 日产化学工业株式会社 The cultural method of vascular smooth muscle cells
CN107532143A (en) * 2015-04-16 2018-01-02 日产化学工业株式会社 Medium additives and culture media composition and the cultural method for having used their cell or tissue

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104640974A (en) * 2012-07-24 2015-05-20 日产化学工业株式会社 Culture medium composition, and method for culturing cell or tissue using said composition
CN105934511A (en) * 2014-01-23 2016-09-07 日产化学工业株式会社 Culture medium composition
CN106414707A (en) * 2014-01-23 2017-02-15 日产化学工业株式会社 Method for producing culture medium composition
CN103865876A (en) * 2014-03-26 2014-06-18 西北民族大学 Method for primary culture of tumor cells
CN107208059A (en) * 2015-01-30 2017-09-26 日产化学工业株式会社 The cultural method of vascular smooth muscle cells
CN107532143A (en) * 2015-04-16 2018-01-02 日产化学工业株式会社 Medium additives and culture media composition and the cultural method for having used their cell or tissue

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110616185A (en) * 2019-09-25 2019-12-27 华东理工大学青岛创新研究院 Multi-cell tumor ball and high-flux preparation method thereof
CN112961821A (en) * 2021-02-24 2021-06-15 四川大学华西医院 Method for efficiently three-dimensionally culturing vascular endothelial cells
CN112961821B (en) * 2021-02-24 2023-05-30 四川大学华西医院 Method for three-dimensional culture of vascular endothelial cells

Similar Documents

Publication Publication Date Title
US11883508B2 (en) Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same
CN103205396B (en) Suspension acclimatization and serum-free acclimatization method for HEK (human embryonic kidney)-293T cells
CN107075476B (en) Method for inducing three-dimensional osteogenic differentiation of stem cells using hydrogel
CN104204191A (en) 3d in vitro bi-phasic cartilage-bone construct
CN101821383B (en) Culture medium and method for in vitro culturing human adult primary mesenchymal stem cells on large scale, primary mesenchymal stem cells obtained by method, uses thereof
CN106591224B (en) Method for separating and purifying high-purity chicken precursor intramuscular fat cells and constructing coculture system of high-purity chicken precursor intramuscular fat cells and muscle satellite cells
CN110607277B (en) Method for differentiating human pluripotent stem cells into macrophages
Ng et al. Dissolvable gelatin‐based microcarriers generated through droplet microfluidics for expansion and culture of mesenchymal stromal cells
WO2024007982A1 (en) Microfluidic biomimetic fiber for producing cell cultured meat, and preparation method therefor and use thereof
CN107075443B (en) Three-dimensional cell culture system and cell culture method using the same
CN111621475A (en) Umbilical cord mesenchymal stem cell membrane and preparation method thereof
CN106834223B (en) Method for inducing differentiation of umbilical cord mesenchymal stem cells into chondrocytes
CN108998441A (en) A kind of three-dimensional nodule ball culture medium additive, culture medium and three-dimensional nodule ball cultural method
Choi et al. In vitro expansion of human adipose-derived stem cells in a spinner culture system using human extracellular matrix powders
Lin et al. Manufacturing human pluripotent stem cell derived endothelial cells in scalable and cell-friendly microenvironments
KR101380561B1 (en) Equine Amniotic Fluid-Derived Multipotent Stem Cells and Method for Producing the Same
TW201923071A (en) Methods for differentiation inducing and producing into beige and white adipocytes
WO2022213704A1 (en) High-migration mesenchymal stem cell, and preparation method therefor and application thereof
CN102250841A (en) Recoverable immortalized rat bone marrow mesenchyme stem cell as well as preparation method and application thereof
Ma et al. Transdifferentiation of fibroblasts into muscle cells to constitute cultured meat with tunable intramuscular fat deposition
CN105087475A (en) Cell culture fluid, application of cell culture fluid and method of inducting DPSCs to differentiate into neuron-like cells
CN115354029A (en) Method for producing neural organoid and neural organoid
CN105624115B (en) Culture medium for inducing human umbilical cord mesenchymal stem cells to differentiate into nerve-like cells and induction method thereof
CN114214285A (en) Application of lncRNA in inhibiting aging of umbilical cord mesenchymal stem cells through high expression
Gao et al. A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181214